Maryam Ziaei - iSono Health, Private Partnering Interview at LSI USA ‘23

Transcription

Maryam Ziaei  0:06  

Hi, I'm Mary. I'm co founders iSono Health. iSono Health is a health technology startup based in San Francisco Bay area. We are developing an AI powered platform combined with Automated Imaging for cancer detection and health monitoring. Our first product that you saw that you can see here is the first of its kind automated 3d breast ultrasound that has been cleared by FDA that the scan as you can see here is a compact, automated ultrasound attaches to a wearable accessory allows for hands free repeatable breast imaging, the whole breast can be captured just two minutes. It's really important that we don't need specialists or ultrasound technologists to capture the image. therefore improving access and expanding access to more point of care settings, outpatient settings, outside radiology and the mission of the companies make sure that every woman everywhere has access to quality breast imaging. The fact that this doesn't require ultrasound technologist or radiologist to operate this system allows for this to be used in any healthcare setting, whether it is PCP or OB GYN or surgeon's office or even a radiology, mobile radiology units or satellite imaging clinics where you know necessarily an expert is not present. It can also help improve the workflow of Radiology, especially with the shortage of ultrasound technologist and medical shortages, measured medical staffing shortages. This is something that can really help make sure that everyone can get access to the necessary best imaging that they need. So we got a CE clearance last year and we are now on our path to commercialize. FDA recently issued a guidance regarding dense breast tissue. About half of women in the US have dense breast which means that a mammogram struggles to find early small lesions in dense breast. And this is something that has been increasingly, women are becoming more aware and FDA issued a guidance and every woman now and us has to be informed and the clinics will be offering alternatives. In addition to mammogram, they'll be offering additional screening and additional best imaging. And breast ultrasound is one of the modalities of choice and the most scalable technology for women who have dense breasts and our technology because of its compactness and automation enables to be enabled use in many, many more settings. So this is the Tusshar scanner. It's an automated 3d breast ultrasound sound. The scanner attaches to a wearable accessory that goes on the patient, we have four sides of the wearable accessory and the height of the wearable accessory is adjustable, so to accommodate different size of patients. Once this wearable was placed on the patient, the patient lives back and the scanner gets attached on top the once the scanner is attached and locked on top, we pour water from into the cup and fill up the cup and afterwards the water is drained into the drain bag. Once everything is in place and the scanner is locked with a press of a button on the software, you can start scanning the whole rest. The wearable allows for a hands free, repeatable image capture without the need for an expert ultrasound technologist or radiologist present. And the whole breast volume is captured in just two minutes by moving the transducer radially along the surface of the breast. And after words, the data the 3d images can be visualized both both on the laptop or tablet and also can be sent to the cloud for remote visualization. We just got FDA cleared and we are wrapping up commercialization. So we're here made a meeting with partners, both our strategic partners, investor investment partners as well as other technology startups who could be a good partner where could partner with us along commercialization path? I think the fact that this is focused on medtech is really important. So you know everybody who's here is interested in medical devices and there's a lot of have really good professional services and, you know, and also investors and strategic partners that all focus on that technology. So both the sessions and the fact that the the network is you know, focus on medtech I think it's important because it makes it high quality more effective in a short period of time.